David Elsley - Net Worth and Insider Trading
David Elsley Net Worth
The estimated net worth of David Elsley is at least $8 Million dollars as of 2024-11-10. David Elsley is the Director, Senior Officer of Cardiol Therapeutics Inc and owns about 2,712,500 shares of Cardiol Therapeutics Inc (TSX:CRDL) stock worth over $8 Million. Details can be seen in David Elsley's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Elsley has not made any transactions after 2019-10-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David Elsley
David Elsley Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Elsley owns 1 companies in total, including Cardiol Therapeutics Inc (TSX:CRDL) .
Click here to see the complete history of David Elsley’s form 4 insider trades.
Insider Ownership Summary of David Elsley
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
TSX:CRDL | Cardiol Therapeutics Inc | 2019-10-15 | Director & Senior Officer |
David Elsley Latest Holdings Summary
David Elsley currently owns a total of 1 stock. David Elsley owns 2,712,500 shares of Cardiol Therapeutics Inc (TSX:CRDL) as of October 15, 2019, with a value of $8 Million.
Latest Holdings of David Elsley
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
TSX:CRDL | Cardiol Therapeutics Inc | 2019-10-15 | 2,712,500 | 2.78 | 7,540,750 |
Holding Weightings of David Elsley
David Elsley Form 4 Trading Tracker
According to the SEC Form 4 filings, David Elsley has made a total of 0 transactions in Cardiol Therapeutics Inc (TSX:CRDL) over the past 5 years. The most-recent trade in Cardiol Therapeutics Inc is the acquisition of 2,500 shares on October 15, 2019, which cost David Elsley around $7,300.
Insider Trading History of David Elsley
- 1
David Elsley Trading Performance
GuruFocus tracks the stock performance after each of David Elsley's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David Elsley is 59.72%. GuruFocus also compares David Elsley's trading performance to market benchmark return within the same time period. The performance of stocks bought by David Elsley within 3 months outperforms 15 times out of 15 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David Elsley's insider trading performs compared to the benchmark.
Performance of David Elsley
David Elsley Ownership Network
Ownership Network List of David Elsley
Ownership Network Relation of David Elsley
David Elsley Owned Company Details
What does Cardiol Therapeutics Inc do?
Who are the key executives at Cardiol Therapeutics Inc?
David Elsley is the Director & Senior Officer of Cardiol Therapeutics Inc. Other key executives at Cardiol Therapeutics Inc include Senior Officer Guillermo Torre , and Director & Senior Officer Christopher James Waddick .
Cardiol Therapeutics Inc (TSX:CRDL) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Cardiol Therapeutics Inc (TSX:CRDL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cardiol Therapeutics Inc (TSX:CRDL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Cardiol Therapeutics Inc (TSX:CRDL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cardiol Therapeutics Inc Insider Transactions
David Elsley Mailing Address
Above is the net worth, insider trading, and ownership report for David Elsley. Currently GuruFocus does not have mailing address information for David Elsley.